Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-19

Clinical Trial Update: Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth [NA]

View source ↗

Summary

A completed pediatric trial examining the effects of rosiglitazone on the metabolic phenotype of impaired glucose tolerance in youth, with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avandia (rosiglitazone)

Snippet

Sponsor: Yale University | Conditions: Obesity, Impaired Glucose Tolerance | NA | Status: COMPLETED | Results posted: 2013-04-19